Marex Group »

Kalvista Pharmaceuticals shares owned by Marex Group

Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by Marex Group from 13F filings

Historical chart of Marex Group investment in Kalvista Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kalvista Pharmaceuticals held by Marex Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalvista Pharmaceuticals by Marex Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $403k 20k 20.13

More positions owned by Marex Group

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Broadcom (AVGO)
Lumentum Hldgs Put Option (LITE)
Microsoft Corporation Call Option (MSFT)
Mastercard Incorporated Cl A Put Option (MA)
UnitedHealth (UNH)
Strategy Cl A New (MSTR)
Tesla Motors (TSLA)
Eli Lilly & Co. Put Option (LLY)
Goldman Sachs Put Option (GS)
Booking Holdings (BKNG)
Sandisk Corp (SNDK)
NVIDIA Corporation Call Option (NVDA)
Valkyrie Bitcoin (BRRR)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)

View all positions for Marex Group

Top funds holding Kalvista Pharmaceuticals

VR Adviser
Frazier Life Sciences Management
Suvretta Capital Management
Tang Capital Management
BlackRock
Capital World Investors
Vanguard Group
Silverarc Capital Management
Point72 Asset Management
Millennium Management
State Street Corporation
Vestal Point Capital
Vanguard Capital Management
Kynam Capital Management
Parkman Healthcare Partners

View all funds holding Kalvista Pharmaceuticals